论文部分内容阅读
LPL基因HindⅢ多态性与2型糖尿病合并脑血管病变及血脂关系
【机 构】
：
济宁医学院附属医院内分泌科 272029
【出 处】
：
中华医学会第八次全国内分泌学学术会议
【发表日期】
：
2009年1期
其他文献
Discovery of Diarylketoxime Derivatives as Potent and Selective MCH-1R Antagonists for the Treatment
1.Background Melanin-concentrating hormone (MCH) is a cyclic 19-amino acid neuropeptide that is predominantly expressed in the central nervous system (CNS).It has been demonstrated that MCH plays an i
会议
CRO in India is a recent development,only a decade and half old.The first five years went mostly in capability building and also in trying to gain credibility.During this time the first few pharmaceut
会议
Background:Diabetes Mellitus is a chronic disease prevailing in modem societies.Contributing factors accounted for diabetes include genetic autoimmune dysfunction and excessive intake of energy that l
会议
Hengruis Discovery and Development Programs on Anti-diabetic Clinical Candidate will be discussed including SP2086 Retagliptin which is in Phase Ⅰ clinical trial in US.
会议
Future Direction and Results of a Diabetes and Hypertension Screening Study of Patients on Concurren
1.Screening Study:Point-of-care glucose testing and a "real-life" metabolic screening checklist were tested in outpatients treated with antipsychotics.The study design was a retrospective,cross-sectio
会议
Identification of Novel Target Genes for the Treatment of Major Depressive Disorders.The role of the interferon (IFN)-system in the pathogenesis of major depressive disorders and depressive side effec
会议
The Discovery of Clinical Candidates CP-316311 and CP-376395 as Antagonists of Corticotrophin-releas
Corticotrophin-releasing factor (CRF),a 41 amino acid peptide,is a key regulator of the hypothalamic-pituitary-adrenal axis in response to stress.It has shown to play an important role in coordinating
会议
Accumulation of amyloid-β (Aβ) peptide is a pathological hallmark of Alzheimers disease (AD).Reduction of Aβ is believed to be a promising approach for the treatment ofAD.Aβ is generated by the proteo
会议